Comparative evaluation of rapid diagnostic tests and microscopy for placental malaria diagnosis among primigravidae after delivery in health care centres in Kwara State, North Central, Nigeria, 2023-2024 [Research] - JIEPH

Research Open Access | Volume 8 (3): Article  59 | Published: 29 Jul 2025

Comparative evaluation of rapid diagnostic tests and microscopy for placental malaria diagnosis among primigravidae after delivery in health care centres in Kwara State, North Central, Nigeria, 2023-2024

   Menu, Tables and Figures

Navigate this article

Table 1: Distribution of study participants across health facility types

Table 2: Socio-demographic Characteristics of the parturient in Ilorin North Central Nigeria, N=654

Table 3: Placental malaria status by sociodemographic characteristics

Table 4: Comparison of RDT and Microscopy Results for Placental Malaria Across Healthcare Institutions

Table 5: Placental Malaria Positivity Rates by Blood Group Using Microscopy and RDT

Table 6: Risk of Placental Malaria Infection Across Blood Groups (Reference: B−)

Table 7: Microscopy and RDT Results of Placental Malaria Across BMI Categories

Table 8: Diagnostic Performance of Malaria Tests Using RDT Among Parturient in Ilorin North

Table 9: Associations Between BMI, Hypertension Status, and Placental Malaria

Keywords

  • Placental malaria
  • Diagnostic methods
  • Prevalence
  • Performance

Adebobola Kehinde Obaniyi1, Sunday Ojo Joseph1,&, Opeyemi Gbenga Oso1

1Parasitology Unit, Department of Zoology, Kwara State University, Malete, Nigeria

&Corresponding author: Sunday Ojo Joseph, Parasitology Unit, Department of Zoology, Kwara State University, Malete, Nigeria, Email: ojo.sunday@kwasu.edu.ng

Received: 11 Dec 2024, Accepted: 20 Jul 2025, Published: 29 Jul 2025

Domain: Maternal and Child Health

Keywords: Placental malaria, Diagnostic methods, Prevalence, Performance

©Adebobola Kehinde Obaniyi et al Journal of Interventional Epidemiology and Public Health (ISSN: 2664-2824). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Cite this article: Adebobola Kehinde Obaniyi et al Comparative evaluation of rapid diagnostic tests and microscopy for placental malaria diagnosis among primigravidae after delivery in health care centres in Kwara State, North Central, Nigeria, 2023-2024. Journal of Interventional Epidemiology and Public Health. 2025;8(3):59. https://doi.org/10.37432/JIEPH-D-24-02037

Abstract

Introduction: Malaria infection in pregnancy can lead to placental malaria, which is linked to negative pregnancy outcomes. This study aimed to evaluate different diagnostic techniques, determine the prevalence, and identify the risk factors associated with placental malaria.
Methods: This hospital-based cross-sectional study was conducted between January 2023 and September 2024 in healthcare facilities in Ilorin North, Kwara State. A total of 654 consenting women participated, with placental blood samples collected at delivery. Malaria diagnosis was performed using RDTs, and Giemsa-stained blood smears were examined microscopically for malaria parasites. Descriptive statistics, chi-square tests, and calculations of sensitivity and specificity were conducted, with a significance level set at p<0.05.
Results: Of the 654 participants 394 (60.24%) were positive for placental malaria by RDT and 375 (57.34%) by microscopy. Only P. falciparum was detected during this study. Blood group O+ had the highest infection at 141 (35.79%) and 135 (36.00%) by RDT and microscopy, while infection was highest among business women, 337/564 and 325/564 by RDT and microscopy. A significant association between placental malaria and blood group was identified using both RDT (χ² = 30.2, p < 0.001) and microscopy (χ² = 46.5, p < 0.001). Ethnicity also showed a significant relationship with malaria detection by microscopy (χ2=9.94, p=0.019). Besides, occupation was significantly associated with malaria positivity by microscopy (χ2=18.5, p<0.001). The diagnostic methods demonstrated good performance, with a sensitivity of 0.9976 (95% CI: 0.9930–1.0023) and a specificity of 0.9094 (95% CI: 0.8779–0.9408). Furthermore, BMI was significantly associated with a decreased likelihood of placental malaria, as higher BMI was linked to a lower risk (aOR = 0.0346, 95% CI: 0.175-0.683).
Conclusion: Placental malaria prevalence in Ilorin North, Kwara State, indicates a significant burden, with younger parturients (ages 26–30) and those in outdoor occupations, such as traders, facing a higher risk. The findings showed the need for continued monitoring and targeted intervention strategies, including improved diagnostic strategies, to address placental malaria in this population.

Introduction

Pregnancy increases vulnerability to malaria, primarily due to the sequestration of infected red blood cells in the placenta, which can lead to chronic infection and placental inflammation [1, 2]. This condition, known as placental malaria, is driven by the expression of VAR2CSA [3], a pregnancy-specific surface antigen that allows the infected red blood cells to bind to chondroitin sulphate A in the placenta. Women, especially those in their first and second pregnancies, are more susceptible to infection because they have not yet developed immunity to parasites expressing VAR2CSA. Placental malaria is a leading cause of low birth weight and preterm births in sub-Saharan Africa, contributing to an estimated 900,000 affected deliveries annually [4]. The sequestration of infected erythrocytes containing mature trophozoite and schizont stages in the placenta, particularly within the intervillous spaces, results in higher parasite densities in the placenta compared to the peripheral circulation [5].

In Nigeria, malaria during pregnancy remains a significant public health challenge, with an estimated 25 million pregnant women at risk annually [6]. The country accounts for a substantial proportion of the global burden of malaria in pregnancy, contributing to high rates of maternal anaemia, low birth weight, and neonatal mortality. Studies in Nigeria have reported varying prevalence rates of placental malaria, ranging from 15% to 40%, depending on geographic location, gravidity, and the use of preventive measures [7, 8]. For instance, a study in Ibadan, Southwestern Nigeria, found a placental malaria prevalence of 69.6% among parturient, with primigravidae being the most affected group [9]. Similarly, in Bauchi, Northeastern Nigeria, a prevalence of 38.4% was reported among primigravidae, highlighting the burden of placental malaria in the region [10].

The burden of malaria during pregnancy is not unique to Nigeria but is a widespread issue across sub-Saharan Africa. In Kenya, for example, a study in the Lake Victoria region reported a placental malaria prevalence of 4.7%, with higher rates observed among primigravidae and women with preeclampsia [11]. In Tanzania, placental malaria prevalence was found to be 15.0%, with significant associations between infection and adverse birth outcomes such as preterm delivery [12]. Similarly, in Uganda, where malaria transmission is perennial, placental malaria prevalence was reported at 26.1%, with primigravidae and secundigravidae being disproportionately affected [13].

The risk of placental malaria is influenced by a combination of biological, environmental, and socioeconomic factors. Primigravidae and secundigravidae are at higher risk due to the lack of immunity to pregnancy-specific malaria parasites expressing VAR2CSA [3]. Environmental factors, such as proximity to stagnant water bodies and seasonal variations in malaria transmission, also play a significant role. For instance, in Burkina Faso, placental malaria prevalence was found to be higher during the rainy season, when mosquito breeding sites are more abundant [14]. Socioeconomic factors, including poverty, age, low educational attainment, and limited access to healthcare, further exacerbate the risk of malaria during pregnancy. In Ghana, a study found that parturient from low-income households were twice as likely to have placental malaria compared to those from higher-income households [15].

Nutritional status, as indicated by Body Mass Index (BMI), and hypertensive disorders during pregnancy are critical factors influencing placental malaria susceptibility. In Nigeria and other African regions, undernutrition, reflected by low BMI, has been associated with increased vulnerability to malaria due to compromised immune function. For instance, a study in Nigeria by Emmanuel et al. [16] found that underweight parturient had a higher prevalence of placental malaria, attributed to weakened immune responses and reduced ability to combat Plasmodium infections. On the other hand, hypertensive disorders, such as preeclampsia, have also been linked to altered placental function, which may create a favourable environment for malaria parasite survival. Oranuka et al. [10] demonstrated that hypertensive parturient in Nigeria were more likely to experience placental malaria, possibly due to impaired placental blood flow and immune dysregulation. Furthermore, it was highlighted that hypertensive disorders in pregnancy are associated with increased oxidative stress and inflammation, which may facilitate malaria parasite proliferation in the placenta [17]. The interaction between BMI and hypertension in influencing placental malaria is biologically plausible, given their shared effects on immune modulation and placental health. For example, underweight parturient with hypertension had a unique immune profile that increased their susceptibility to malaria [18].

The consequences of placental malaria extend beyond maternal health, significantly impacting neonatal outcomes. Placental malaria is associated with intrauterine growth restriction, low birth weight, and increased neonatal mortality [19]. In Mozambique, a study found that infants born to mothers with placental malaria had a 40% higher risk of low birth weight compared to those born to uninfected mothers [20]. Similarly, in Bangladesh, malaria in pregnancy was linked to a 2.5-fold increase in the risk of preterm birth, highlighting the urgent need for effective prevention and management strategies [21].

Current recommendations for preventing malaria during pregnancy include the use of intermittent preventive treatment with sulfadoxine-pyrimethamine (SP-IPT) after the first trimester, insecticide-treated bed nets (ITNs), and prompt case management [22, 23]. These interventions have been shown to significantly reduce the burden of placental malaria, maternal anaemia, and adverse birth outcomes in malaria-endemic regions. However, the effectiveness of these strategies is often compromised by systemic and operational challenges, including delayed antenatal care (ANC) enrollment, poor adherence to preventive measures, and the emergence of drug resistance [24–26].

Prompt case management of malaria during pregnancy is critical to reducing maternal and foetal morbidity. However, diagnostic and treatment delays are common in many African countries. In Tanzania, for example, a study found that only 50% of parturient with malaria symptoms received prompt treatment, with delays attributed to stockouts of antimalarial drugs and inadequate health worker training on diagnostic methods [27].

Various diagnostic techniques, including placental blood smears, histology, rapid diagnostic test tests, and polymerase chain reaction (PCR), have been employed  to assess  placental malaria in sub-Saharan Africa [28]. Placental histology is considered the gold standard for diagnosing malaria during pregnancy, as it can detect both active and past infections based on the presence of infected erythrocytes and malaria pigment [29]. However, due to limited expertise and resources in endemic regions, this method is not widely available. Consequently, many studies in sub-Saharan Africa rely on placental blood smears or RDT, which are more accessible but may vary in sensitivity and specificity.

In Nigeria, the use of rapid diagnostic tests (RDTs) for diagnosing placental malaria has gained attention due to their ease of use, rapid results, and suitability for resource-limited settings. RDTs detect malaria antigens, such as histidine-rich protein 2 (HRP-2) and lactate dehydrogenase (LDH), providing a practical alternative to microscopy and histology, which require specialized equipment and expertise. However, studies comparing the performance of RDTs with microscopy or histology for placental malaria diagnosis have yielded mixed results, indicating the need for specific validation.

A study in Yaoundé, Cameroon, reported a sensitivity of 96.15% and specificity of 80.76% for RDTs compared to placental histology, demonstrating their potential as a reliable diagnostic tool in urban settings [30]. In contrast, a study in Eastern Sudan found lower specificity (57.7%) for RDTs in detecting placental malaria, particularly in cases with low parasite density, underscoring the variability in RDT performance across different settings [31]. Similarly, in Uganda, a study reported a sensitivity of 80.9% and specificity of 87.85% for RDTs compared to placental blood smears [32].

The performance of RDTs in diagnosing placental malaria is influenced by several factors, including the type of antigen targeted, the timing of testing, and the presence of residual antigens from cleared infections. HRP-2-based RDTs, which are widely used in sub-Saharan Africa, have been shown to remain positive for weeks after effective treatment, potentially leading to false-positive results [33]. In Papua New Guinean, a study found that HRP-2-based RDTs had a positive predictive value of only 68.4% for placental malaria, largely due to the persistence of HRP-2 antigens in the bloodstream [34].

The emergence of P. falciparum strains with HRP-2 gene deletions poses a significant challenge to the reliability of HRP-2-based RDTs. Recently in Southern Ethiopia, a study reported a high prevalence of pfhrp2/3 deletions, leading to false-negative RDT results in confirmed malaria cases [35]. Similarly, pfhrp2/3 gene deletions were detected in some provinces surveyed in Mozambique, raising concerns about the continued use of HRP-2-based RDTs in these regions [36].

Despite these challenges, RDTs remain a valuable tool for diagnosing placental malaria, particularly in settings where microscopy and histology are unavailable. In Colombia, a study found that RDTs had a sensitivity of 92.5% and specificity of 100% compared to placental histology, with higher accuracy observed when testing was performed at delivery [37]. In Cameroon, RDTs were shown to be more effective than clinical diagnosis in identifying placental malaria cases, leading to improved case management and reduced adverse outcomes [30]. However, the integration of RDTs into routine antenatal care requires training for healthcare workers, quality assurance programs, and strategies to address supply chain challenges.

The validation of RDTs for placental malaria diagnosis is particularly critical among primigravidae, who are at the highest risk of adverse outcomes due to their lack of immunity to pregnancy-specific malaria parasites. In African countries, studies found a higher accuracy observed in high-transmission areas compared to low-transmission areas [32, 34]. Similarly, in another African nation, RDTs were shown to be more effective in detecting placental malaria in primigravidae than in multigravidae, supporting their use in targeted interventions for high-risk groups [38].

The mixed performance of RDTs across different African settings shows the importance of specific validation and the need for standardized diagnostic criteria. This study aims to contribute to this body of knowledge by evaluating the diagnostic accuracy of placental RDTs compared to microscopy among primigravidae in Kwara State, Nigeria. By focusing solely on placental malaria, this study provided insights into the diagnostic accuracy of RDTs in a high-risk population and contributed to the development of more effective strategies for managing malaria during pregnancy in resource-limited settings.

Methods

Study area and population
The study was conducted in Ilorin North Local Government Area (LGA), Kwara State, from January 2023 to September 2024. Ilorin North, an urban centre in the Kwara North Senatorial Zone, has experienced significant urbanization over the past decade, with its population exceeding 900,000 as of 2022. Data was collected from health facilities at various levels—primary, secondary, tertiary, and private—offering antenatal, preventive, and curative services. The region is predominantly inhabited by Yoruba, Hausa, and Fulani ethnic groups, with Islam and Christianity as the major religions [39]. Annual temperatures range between 22°C and 34°C, with the hottest months being February and March (32–34°C) and the coolest months, December and January (22–25°C) [40]. Relative humidity fluctuates, reaching up to 80% during the wet season and dropping to around 35% during the dry season, influenced by daily weather variations [41].

Study Design and Setting
This study was a cross-sectional comparative evaluation of placental rapid diagnostic tests (RDTs) and microscopy for the diagnosis of placental malaria among primigravidae who had received antenatal care in urban health facilities in Kwara State, North Central Nigeria. Participants who had completed 28 weeks of gestation were recruited [9]. They were followed up and placental blood samples were collected at the point of delivery in the maternity wards of the same facilities.

 Sample Size Determination
The sample size (n) was calculated using the Cochran’s sample size formula [42] with a precision of 5%, and a z score of 1.96 for a 95% confidence level, error margin  (e) of 0.0437 and a p of 0.5 [43]. Based on these parameters, a minimum sample size of 503 participants was required. To account for potential exclusions and non-responses, an additional 30% was added to the minimum required sample size. The final sample size was therefore adjusted to 654 parturients.

\[
n = \frac{Z^2 \cdot P \cdot (1 – 0.5)}{e^2}
\]

\[
n = \frac{(1.96)^2 \times 0.5 \times (1 – 0.5)}{(0.0437)^2}
\]

n = 502.6 ~503

Sampling Technique
A multistage sampling technique was employed to select participants. In the first stage, six health facilities were purposively selected based on their patient load and representation of urban settings. In the second stage, random sampling was used to enrol primigravidae who met the inclusion criteria (first-time parturient aged 18–45 years, attending health care facilities). Women with multiple pregnancies, severe anaemia, or chronic illnesses were excluded.

Health Facility Selection
In Nigeria, the health system is structured into primary, secondary, tertiary, and private health institutions, each serving distinct roles. Primary health institutions, such as Primary Healthcare Centers (PHCs), deliver basic preventive, promotive, and curative services to local communities, forming the foundation of healthcare delivery [44]. Secondary health institutions, including general hospitals, provide specialized services and inpatient care, acting as referral centres for primary facilities [45]. Tertiary health institutions, such as teaching hospitals and specialized medical centres, offer advanced medical services, including specialized diagnostics and treatment, and serve as referral hubs for secondary institutions [46]. In addition, private healthcare facilities play a significant role by catering to individuals who can afford their services, often at higher costs compared to public institutions.

For this study, six urban health facilities were included in the study: two primary healthcare centres, one secondary hospital, one tertiary hospital, and two private health centres. The facilities were purposively selected to ensure representation of the diverse healthcare delivery systems within urban settings. The selection criteria included a high volume of delivery cases, availability of laboratory facilities, and willingness to participate in the study. This approach ensured a comprehensive evaluation of placental malaria diagnostic methods in urban healthcare environments.

Participant Selection Procedure
Eligible participants were primigravidae who planned to deliver in the selected facilities. At each facility, a line list of eligible parturient was generated from the antenatal register. From this sampling frame, simple random sampling was employed using random numbers to select the required number of participants per facility (Table 1).

Laboratory Procedures

Placental Blood Collection Procedure
Placental blood was collected immediately after delivery to minimize the risk of maternal blood contamination. Following delivery, the placenta was placed in a sterile container and transported to the laboratory within 30 minutes to maintain sample integrity [47]. A trained laboratory technician collected the blood by making a small incision on the maternal side of the placenta and aspirating blood from the intervillous spaces using a sterile syringe into an ethylenediaminetetraacetic acid (EDTA) bottle. To prevent contamination with maternal blood, the first few drops were discarded, and only blood from the deeper intervillous spaces was collected [47]. The collected blood was then divided into aliquots for rapid diagnostic tests (RDT), microscopy, and blood grouping, ensuring comprehensive analysis for diagnosis.

Rapid Diagnostic Test (RDT) for Placental Malaria
Placental malaria rapid diagnostic tests (RDTs) were conducted using a commercially available HRP-2-based kit, following the manufacturer’s instructions. The procedure involved applying 5 µL of placental blood to the test strip, followed by the addition of 2–3 drops of buffer solution to the sample well. Results were interpreted after 15–20 minutes, with a positive result indicated by the presence of both the control and test lines, and a negative result confirmed by the appearance of only the control line. This method provides a rapid and reliable approach for detecting placental malaria, particularly in resource-limited settings [37].

Microscopy
For each participant, both thick smear and thin film were prepared from placental blood on clean glass slides. The smears were air-dried before staining. The thick smears were stained with 10% Giemsa stain for 10 minutes to enhance parasite visibility. Microscopic examination of the thick smears was used to detect the presence of malaria parasites, while thin films were used to determine the Plasmodium species in cases where thick films were positive. Two independent microscopists, blinded to the rapid diagnostic test (RDT) results, examined the slides under a light microscope using a 100x oil immersion lens. In cases where the two microscopists reported discordant results, such as disagreement on the presence or absence of parasites, a third, more experienced microscopist was consulted to review the slides. Parasite density was quantified by counting the number of parasites per 200 white blood cells (WBCs) and extrapolating to parasites per microliter (µL), based on an assumed average WBC count of 8,000/µL [48].

Blood Grouping
Blood grouping was conducted using the slide agglutination method, a common technique for determining ABO and Rh blood types. In this procedure, a drop of placental blood was placed on a clean glass slide, and separate drops were mixed with Anti-A, Anti-B, and Anti-D sera. After a 2-minute incubation period, agglutination was observed to identify the blood group. The presence or absence of agglutination with each antiserum allowed for the determination of the ABO type (A, B, AB, or O) and the Rh status (positive or negative) [49].

Inclusion and Exclusion Criteria
We included primigravidae aged 18–45 years who were attending antenatal care (ANC) and were followed until delivery at the selected urban health facilities. Participants were required to provide written informed consent to be eligible for inclusion.

Parturients with multiple pregnancies, such as twins or triplets, were excluded from the study. Besides, those with severe anaemia (haemoglobin < 7 g/dL), chronic illnesses like diabetes or HIV/AIDS, or a history of antimalarial drug use within the past four weeks were not eligible. Women with incomplete medical records or those unwilling to participate were also excluded.

Socio-Demographic and Clinical Data Collection
Socio-demographic data, including age, education, occupation, ethnicity, religion, and marital status, were collected using a structured questionnaire. Trained research assistants administered the questionnaire through face-to-face interviews before delivery to ensure accurate and reliable data collection.

Anthropometric and Clinical Measurements
Body Mass Index (BMI) was calculated using weight and height measurements obtained with a calibrated scale and stadiometer, respectively. BMI was derived as weight in kilograms divided by height in meters squared [50]. Hypertension status was assessed using a digital sphygmomanometer, with hypertension defined as a systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg, recorded on two separate occasions [51].

Quality Control Activities
To ensure the quality and reliability of the study, several quality control measures were implemented. All study research team underwent comprehensive training on data collection, placental blood sampling, and laboratory procedures to ensure consistency and accuracy in their work. RDT kits were purchased and delivered by the study team, with storage temperatures maintained through continuous temperature monitoring during storage. All laboratory tests, including rapid diagnostic tests (RDT), microscopy, and blood grouping, were conducted using standardised protocols to minimise variability and enhance reproducibility. In addition, microscopists were blinded to the RDT results to prevent potential bias during the analysis. To further ensure accuracy, a third microscopist independently reviewed the slides, and any discrepancies were resolved.

Regular calibration of laboratory equipment was performed to maintain precision and reliability in measurements. Data validation was also a critical component of the quality control process. Collected data were double-entered and cross-checked to identify and correct any errors, ensuring the integrity of the dataset. These measures collectively contributed to the robustness and credibility of the study findings.

Index Test and Reference Test
The rapid diagnostic test (RDT) was employed as the index test in this study. A commercially available HRP-2-based RDT kit, specifically the First Response (Premier Medical Corporation Private Limited, A1 302 GIDC Sarigam Dist. Valsad, Gujarat, India. MFG/MD/2018/000064), was used following the manufacturer’s instructions. This test is designed to detect P. falciparum malaria antigens, providing a rapid and accessible diagnostic tool for malaria infection.

The reference standard for this study was placental blood microscopy. Thick blood smears were prepared, stained with Giemsa, and examined under a light microscope by two independent microscopists to confirm the presence of malaria parasites. This dual-assessment approach ensured the reliability and validity of the diagnostic outcomes, minimising the risk of misdiagnosis.

Data analysis
Data was entered into Microsoft Excel and analyzed using STATA version 14 (Stata Corp, College Station, TX, USA). Proportions were compared using the Chi-squared test. Pearson’s Chi-squared (χ²) test assessed associations between malaria diagnostic methods and variables such as sociodemographic characteristics, BMI, and blood group. Regression analysis examined the relationships between BMI, hypertension status, and placental malaria. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy of the RDT were calculated using microscopy as the gold standard, and Cohen’s kappa assessed agreement. Statistical significance was defined as p <0.05.

Ethical Considerations
The study was reviewed and approved by the Kwara State Ministry of Health Review Board (ERC/MOH/2022/003/019). Written informed consent was obtained from all participants before enrollment. Participants were informed of the study objectives, procedures, risks, and benefits, and were assured of confidentiality and the right to withdraw at any time without affecting their access to care.

Results

Socio-demographic characteristics of the parturient women
The sociodemographic characteristics of parturient recruited for the study are summarized as follows. The majority of the participants were aged 26–30 years (39.5%), with a mean age of 27.6 ± 4.5 years, while the lowest representation was among parturient aged 41 years and above (0.5%). Most participants were Yoruba (90.9%), followed by Igbo (3.1%), with the least represented ethnic group being Fulani (2.3%). Regarding religion, Islam was the predominant faith (78.3%), while Christianity accounted for 21.7%. Educational attainment was highest at the secondary level (43.0%) and lowest among those with no formal education (7.0%). The most common occupation was business or self-employment (81.0%) (Table 2).

Relationship between sociodemographic characteristics and placental malaria
Only Plasmodium falciparum was detected during this study. Of the 654 participants 394 (60.24%) were positive for placental malaria by RDT and 375 (57.34%) by microscopy. The 26-30 age group had the highest number of positive cases for both RDT 174 (44.16%) and microscopy 163 (43.47%), while the ≥41 age group had the lowest number of positive cases. There was a significant association between malaria status and age group by RDT (χ2=11.3, p = 0.046). The majority were of Yoruba ethnicity (601, 91.96%), with 358 (90.86%) tested positive by RDT. The Igbo group had 17 (4.31%) positive cases, while Fulani and Hausa groups had 7 and 12 positive cases each, respectively by RDT. The association between ethnicity and malaria by RDT was not significant (χ² = 6.70, p = 0.082); however, the association between ethnicity and malaria by microscopy was statistically significant (χ² = 9.94, p=0.019). By RDT method, 177 (44.92%) parturient with secondary education and 133 (33.76%) women with tertiary education tested positive. The association between educational level and malaria by RDT was not statistically significant (χ2=5.01, p=0.171).

A total of 530 parturient engaged in business or trading, 337 (85.53%) tested positive while 15 unemployed parturient (3.81%) tested positive by RDT. The association between occupation and malaria positivity by RDT was statistically significant (χ2=13.5, p=0.004). The association between occupation and malaria positivity by microscopy was also statistically significant (χ2=18.5, p<0.001). The highest prevalence of placental malaria was observed among parturient practicing Islam for both RDT (78.93%) and microscopy (78.67%). Statistical analysis showed no significant association between religion and placental malaria prevalence, RDT (χ2=0.234, p=0.62) and microscopy (χ2=0.074, p=0.79) (Table 3).

Distribution of Placental Malaria Among Parturient by Test Type and Healthcare Institution
Of the total of 654 parturient, based on RDT, the highest prevalence was observed in secondary institutions (33.0%), while the lowest was in private facilities (18.5%). For microscopy, secondary institutions also recorded the highest prevalence (31.47%), whereas private institutions had the lowest (19.47%) (Table 4).

Blood Group-Wise Comparison of Placental Malaria Detection by Microscopy and RDT
Among the patients who tested negative by RDT, blood group O+ had the highest proportion (35.0%), while the lowest proportion was observed in B- (1.54%). Among the patients who tested positive by RDT, blood group O+ again had the highest prevalence (35.79%) while the lowest found in O- (0.76%). A significant association between placental malaria and blood group was observed by RDT (χ² = 30.2, p < 0.001). For the microscopy results, the highest prevalence was seen in blood group O+ (36.0%), while those with O- showed the lowest prevalence (0.27%). A significant association was also found between placental malaria and blood group by microscopy (χ² = 46.5, p < 0.001) (Table 5).

Risk Analysis in relation to blood group
The risk of the placental malaria infection analysis among parturient revealed significant variations in the odds of infection across different blood groups (reference group B-). Parturient with blood group AB had the highest odds of placental malaria (OR = 3.13, 95% CI: 1.96–5.01), followed by those with blood group A+ (OR = 1.69, 95% CI: 1.24–2.32), and these associations were statistically significant. In contrast, parturient with blood group O- had the lowest odds (OR = 0.11, 95% CI: 0.03–0.48) and was statistically significant. (Table 6)

Relationship Between Body Mass Index (BMI) and Placental Malaria
The analysis of placental malaria in relation to BMI categories revealed significant associations between both RDT and microscopy results. Among parturient with a normal BMI, 41.88% tested positive for placental malaria by RDT and 42.40% by microscopy. Underweight parturient had the lowest percentage of positive cases, with 8.38% by RDT and 8.53% by microscopy. These associations were statistically significant (χ² = 16.27, p < 0.001 for RDT, and χ² = 16.59, p < 0.001 for microscopy) (Table 7).

Agreement Between RDT and Microscopy
The diagnostic performance measures for malaria tests using the RDT and microscopy methods among parturient in Ilorin North is shown in Table 8. Sensitivity was very high at 0.9976 (95% CI: 0.9930-1.0023) as well as the specificity (0.9094 [95% CI: 0.8779-0.9408]). The positive predictive value is 0.9356 (95% CI: 0.9129-0.9582), while the negative predictive value is 0.9966 (95% CI: 0.9899-1.0033). Accuracy, representing the overall correctness of the test, is 0.9596 (95% CI: 0.9454-0.9737), showing that the test performs reliably. The Cohen’s kappa analysis showed a high agreement between the RDT and microscopy for placental malaria detection (κ = 0.92, p < 0.001). The observed agreement was 96.09%, substantially higher than the expected agreement by chance alone (51.43%).

Interaction Analysis
A logistic regression analysis was performed to explore the relationship between Body Mass Index (BMI), hypertension status, and their interaction on the likelihood of placental malaria detected by a rapid diagnostic test (RDT) among parturient in Ilorin North, Kwara State. These variables were selected a priori based on their biological plausibility and known associations with both maternal immunity and susceptibility to malaria infection during pregnancy. The analysis revealed that BMI was significantly associated with a decreased likelihood of placental malaria, with higher BMI linked to a lower risk (aOR = 0.346, 95% CI:0.175-0.683). Hypertension status did not show a significant effect on placental malaria (aOR =0.718 , 95% CI:0.381-1.352 ). Interaction terms indicated that underweight parturient with hypertension had a significantly lower likelihood of placental malaria (aOR =0.045-, 95% CI:0.003-0.788 ) (Table 9). Similarly, parturient with normal BMI and normal blood pressure, as well as overweight parturient with normal blood pressure, were significantly less likely to test positive for placental malaria (aOR =0.149, 95%CI:0.038-0.578; aOR = 0.408, 95% CI:0.186-0.895, respectively).

Discussion

The results on the prevalence of placental malaria among parturient at different health care facilities in Ilorin North, Kwara State, Nigeria demonstrated consistency between two diagnostic methods: Rapid Diagnostic Test (RDT) and microscopy. The high prevalence of placental malaria among parturient suggest a substantial burden of malaria in parturient in the studied areas, which could have serious implications for maternal and foetal health. This results is higher than 27.7% recorded in Colombia [52], and 44.6% in Uganda [53].  The observed differences in prevalence may be attributed to several factors, including variations in malaria transmission intensity, healthcare infrastructure, and population characteristics. For instance, the current studied areas are known for higher endemicity of malaria due to environmental factors such as climate, vector density, and limited access to effective malaria control interventions [54, 55].

The highest infection rates in the 26-30 age group suggest that this demographic may be at higher risk of placental malaria, potentially due to factors such as increased exposure to malaria vectors or lower immune responsiveness compared to younger or older parturient. This demographic should be prioritized in public health interventions by health practitioners, such as focused malaria prevention measures and education [56]. The lower infection rates in the 36-40 age group could indicate that older women have a greater acquired immunity against malaria or that they have a more robust immune response [3], which is an important aspect to consider when designing tailored health interventions.

The observation that business/trading occupations had the highest positive rates (85.53% for RDT and 86.67% for microscopy) may reflect the mobility and extended outdoor exposure inherent in these professions. Traders, for instance, may frequently travel to malaria-endemic rural markets or spend extended hours in areas with high mosquito vector densities, increasing their risk of infection [57]. This pattern emphasizes the need for malaria control programs tailored to occupational risks, such as promoting the use of insecticide-treated nets (ITNs) and advocating for protective measures during high-risk activities. Conversely, civil servants (i.e. government workers at local, state, or federal) exhibited the lowest rates of infection. This may indicate better access to healthcare resources, higher socioeconomic status, and a greater likelihood of residing in urban areas with improved malaria control measures [58]. These results support the notion that socioeconomic factors, often linked to occupational categories, significantly affect malaria exposure and prevention outcomes. The strong correlation between occupation and malaria prevalence indicates the potential for occupation-based malaria interventions. Parturient in high-risk occupational groups, such as traders, could benefit from targeted education campaigns and prevention strategies, such as malaria prophylaxis or the distribution of long-lasting insecticide-treated nets.

The distribution of positive cases, with the majority observed among parturient with secondary and tertiary education, aligns with their higher representation in the study population. This result is at variance with similar study [59], where there a commonly held assumptions that higher education levels are inherently linked to improved health outcomes. Parturient with no formal education accounted for the lowest proportion of positive cases, possibly reflecting their lower overall participation rather than a protective effect against malaria.

The observed significant association between ethnicity and placental malaria infection, as indicated by the chi-square tests for RDT and microscopy (p < 0.001), suggests that ethnicity may play a role in the risk of infection among parturients in Ilorin North. The Yorubas, representing the largest proportion of the study population, also accounted for the majority of both RDT-positive and microscopy-positive cases. This high prevalence may be influenced by cultural, environmental, or socioeconomic factors [60, 61], specific to this group. For example, their living conditions or proximity to malaria-prone areas may increase exposure to mosquito vectors. The comparatively low rates of infection among the Hausa and Fulani groups may reflect differences in housing types or preventive behaviours.

The significant association between BMI and placental malaria infection showed the role of nutritional and physiological factors in influencing malaria susceptibility during pregnancy [59]. Parturient with normal BMI exhibited the highest infection rates, which could reflect the physiological vulnerability of this group to malaria. A normal BMI might correlate with optimal metabolic and immune functions, which paradoxically may provide a favourable environment for Plasmodium parasites to thrive and evade host defences mechanism. In contrast, the lower infection rates observed among obese and overweight parturient could suggest a protective effect linked to higher adiposity [62]. Adipose tissue has been shown to modulate immune responses [63], possibly altering the inflammatory pathways associated with malaria pathogenesis. Moreover, the physical or hormonal changes associated with higher BMI might influence vector exposure or parasite development. The underweight group, though small, showed a relatively high infection. This aligns with previous evidence that malnutrition can impair immune defences [64], making individuals more susceptible to infections, including malaria.

The significant relationship between blood group and placental malaria infection aligns with previous research suggesting that genetic and immunological factors associated with blood groups influence susceptibility to malaria [65]. The higher proportion of RDT-positive and microscopy-positive results among parturient with blood group A+ may be attributed to differences in erythrocyte membrane characteristics, which could affect the binding efficiency of Plasmodium parasites [66]. Blood group O+, which showed the highest frequency of negative results, has been associated with reduced rosetting [67], a key factor in malaria pathogenesis. The substantial positivity observed in blood group AB might reflect an intermediate susceptibility, potentially influenced by the presence of both A and B antigens. Conversely, the lower infection rates in blood groups A- and O- could be due to the protective effects linked to the Rh-negative phenotype, which may modulate immune responses or parasite survival [65].

The interaction term (underweight by hypertensive) revealed a significant inverse relationship between being underweight and hypertensive status, which implies that underweight parturient with hypertension have a markedly lower risk of placental malaria infection. This finding could suggest that hypertensive parturient who are also underweight may experience changes in their immune response or other physiological factors that reduce susceptibility to infection. This result, while somewhat unexpected, warrants further investigation to understand the underlying mechanisms, as it may offer a unique perspective on how hypertension and BMI interact in placental malaria. The interaction between normal BMI and absence of hypertension also demonstrated a significant protective effect for parturientwith a normal BMI and absence of hypertension, indicating that these parturients are less likely to experience placental malaria infection compared to those in other BMI and hypertension categories. This result aligns with existing studies that suggest normal BMI may be associated with better general health and a reduced likelihood of malaria infection due to a potentially stronger immune system [59, 68].

Limitation
One limitation of this study is the non-inclusion of the design effect, which may introduce some level of clustering bias. While this was a necessary trade-off for feasibility, the study’s findings remain methodologically sound and provide valuable insights into the research.

Conclusion

The prevalence of placental malaria among parturients in Ilorin North, Kwara State, Nigeria, indicates a significant burden of malaria, with an obvious association between age (26-30 years), occupation (i.e traders), and Yoruba ethnic groups.  The data suggest that younger parturient, particularly those in the 26-30 age group, as well as those in occupations (i.e traders) with high outdoor exposure, such as traders, are at greater risk. The findings indicate the importance of targeted malaria interventions tailored to specific risk factors, including occupation, age, and ethnicity, to ensure high-risk groups receive the necessary prevention strategies. The diagnostic methods demonstrated good performance, with a high sensitivity and specificity.  The findings showed the need for continued monitoring and targeted intervention strategies, including improved diagnostic strategies, to address placental malaria in this population.

What is already known about the topic

  • Women, especially those in their first and second pregnancies, are more susceptible to malaria infection
  • Placental malaria is detected by histological methods

What this  study adds

  • This study showed that there are agreement between placental malaria detection by microscopy and RDT methods
  • We found that BMI is associated with placental malaria

Competing Interest

The authors of this work declare no competing interest

Funding

The authors did not receive any specific funding for this work

Acknowledgements

We are grateful to all the participants for giving their consent to participate in this study.

Authors´ contributions

JOS, conceptualized the study. JOS, OKA, and OGO designed the study. OKA participated in fieldwork and data collection. OKA and OGO performed the data analysis; OKA, and OGO interpreted the data. JOS, OKA, and OGO prepared the first draft of the manuscript, reviewed by JOS and OGO. All authors contributed to the development of the final manuscript and approved its submission.

Tables & Figures

Table 1: Distribution of study participants across health facility types
Facility type Number of facilities Participants per facility Total participants Percentage (%)
Tertiary Health Facility 1 189 189 28.9
Secondary Health Facility 1 195 195 29.8
Private Health Facilities 2 81 162 24.8
PHC Facilities 2 54 108 16.5
Total 6 654 100
Table 2: Socio-demographic Characteristics of the parturient in Ilorin North Central Nigeria, N=654
Variables Frequency Percentage
Age Group
≤20 20 3.06
21–25 230 35.17
26–30 258 39.45
31–35 106 16.21
36–40 37 5.66
≥41 3 0.46
Ethnicity
Yoruba 601 91.9
Hausa 18 2.8
Fulani 15 2.3
Igbo 20 3.0
Religion
Christianity 142 21.7
Islam 512 78.3
Educational Level
No formal 46 7.0
Primary 104 15.9
Secondary 281 43.0
Tertiary 223 34.1
Occupation
Farming/Fishing 11 1.68
Business/Self Employed 530 81.04
Civil Servants 82 12.54
Unemployed 31 4.74
Table 3: Placental malaria status by sociodemographic characteristics
Characteristics RDT Microscopy
-ve +ve -ve +ve
Age
≤20 9 (3.46%) 11 (2.79%) 10 (3.58%) 10 (2.67%)
21–25 96 (36.92%) 134 (34.01%) 101 (36.20%) 129 (34.40%)
26–30 84 (32.31%) 174 (44.16%) 95 (34.05%) 163 (43.47%)
31–35 52 (20.00%) 54 (13.71%) 54 (19.35%) 52 (13.87%)
36–40 18 (6.92%) 19 (4.82%) 18 (6.45%) 19 (5.07%)
>41 1 (0.38%) 2 (0.51%) 1 (0.36%) 2 (0.53%)
χ², p-value (χ²=11.3, p=0.046) (χ²=7.8, p=0.167)
Ethnicity
Yoruba 243 (93.46%) 358 (90.86%) 259 (92.83%) 342 (91.20%)
Hausa 6 (2.31%) 12 (3.05%) 7 (2.51%) 11 (2.93%)
Fulani 8 (3.08%) 7 (1.78%) 10 (3.58%) 5 (1.33%)
Igbo 3 (1.15%) 17 (4.31%) 3 (1.08%) 17 (4.53%)
Total 260 (100%) 394 (100%) 279 (100%) 375 (100%)
χ², p-value (χ²=6.70, p=0.082) (χ²=9.94, p=0.019)
Educational Level
No Formal Education 25 (9.62%) 21 (5.33%) 26 (9.32%) 20 (5.33%)
Primary 41 (15.77%) 63 (15.99%) 44 (15.77%) 60 (16.00%)
Secondary 104 (40.00%) 177 (44.92%) 111 (39.78%) 170 (45.33%)
Tertiary 90 (34.62%) 133 (33.76%) 98 (35.13%) 125 (33.33%)
χ², p-value (χ²=5.01, p=0.171) (χ²=4.92, p=0.178)
Occupation
Farming/Fishing 7 (2.69%) 4 (1.02%) 7 (2.51%) 4 (1.07%)
Business/Trading 193 (74.23%) 337 (85.53%) 205 (73.48%) 325 (86.67%)
Civil Servants 44 (16.92%) 38 (9.64%) 50 (17.92%) 32 (8.53%)
Unemployed 16 (6.15%) 15 (3.81%) 17 (6.09%) 14 (3.73%)
χ², p-value (χ²=13.5, p=0.004) (χ²=18.5, p<0.001)
Religion
Christian 59 (22.69%) 83 (21.07%) 62 (22.22%) 80 (21.33%)
Islam 201 (77.31%) 311 (78.93%) 217 (77.78%) 295 (78.67%)
χ², p-value (χ²=0.234, p=0.62) (χ²=0.074, p=0.79)
Table 4: Comparison of RDT and Microscopy Results for Placental Malaria Across Healthcare Institutions
Test RDT Microscopy
PHC (n=108) Secondary (n=195) Tertiary (n=189) Private (n=162) PHC (n=108) Secondary (n=195) Tertiary (n=189) Private (n=162)
Negative 36 (13.9) 65 (25.0) 70 (26.9) 89 (34.2) 36 (12.90%) 77 (27.60%) 77 (27.60%) 89 (31.90%)
Positive 72 (18.3) 130 (33.0) 119 (30.2) 73 (18.5) 72 (19.20%) 118 (31.47%) 112 (29.87%) 73 (19.47%)
Total 108 (16.5) 195 (29.8) 189 (28.9) 162 (24.8) 108 (16.51%) 195 (29.82%) 189 (28.90%) 162 (24.77%)
Table 5: Placental Malaria Positivity Rates by Blood Group Using Microscopy and RDT
Blood Group RDT Microscopy
-ve +ve -ve +ve
A+ 49 (18.85%) 88 (22.34%) 51 (18.28%) 86 (22.93%)
A− 11 (4.23%) 12 (3.05%) 11 (3.94%) 12 (3.20%)
B+ 69 (26.54%) 77 (19.54%) 75 (26.88%) 71 (18.93%)
B− 4 (1.54%) 8 (2.03%) 4 (1.43%) 8 (2.13%)
AB+ 20 (7.69%) 65 (16.50%) 23 (8.24%) 62 (16.53%)
O+ 91 (35.00%) 141 (35.79%) 97 (34.77%) 135 (36.00%)
O− 16 (6.15%) 3 (0.76%) 18 (6.45%) 1 (0.27%)
p-value (χ² = 30.2, p < 0.001) (χ² = 46.5, p < 0.001)
Table 6: Risk of Placental Malaria Infection Across Blood Groups (Reference: B−)
Blood Group Positive Negative Odds 95% CI
A+ 105 62 1.69355 1.23727 – 2.31809
A− 14 20 0.7 0.35358 – 1.38584
B+ 83 82 1.0122 0.74598 – 1.37340
AB+ 72 23 3.13043 1.95763 – 5.00587
O+ 138 112 1.23214 0.96029 – 1.58095
O− 2 18 0.11111 0.02578 – 0.47886
Table 7: Microscopy and RDT Results of Placental Malaria Across BMI Categories
BMI (kg/m²) RDT Microscopy
-ve (n=260) +ve (n=394) -ve (n=279) +ve (n=375)
Underweight (< 18.5) 3 (1.15%) 33 (8.38%) 4 (1.43%) 32 (8.53%)
Normal (18.5–24.9) 111 (42.69%) 165 (41.88%) 117 (41.94%) 159 (42.40%)
Overweight (25.0–29.9) 83 (31.92%) 116 (29.44%) 90 (32.26%) 109 (29.07%)
Obese (≥ 30.0) 63 (24.23%) 80 (20.30%) 68 (24.37%) 75 (20.00%)
p-value (χ² = 16.27, p < 0.001) (χ² = 16.59, p < 0.001)
Table 8: Diagnostic Performance of Malaria Tests Using RDT Among Parturient in Ilorin North
Variables Value 95% CI SE
Sensitivity 0.9976 0.9930 – 1.0023 0.0024
Specificity 0.9094 0.8779 – 0.9408 0.0160
Positive Predictive Value 0.9356 0.9129 – 0.9582 0.0116
Negative Predictive Value 0.9966 0.9899 – 1.0033 0.0034
Accuracy 0.9596 0.9454 – 0.9737 0.0072
Positive Likelihood Ratio 11.0086
Negative Likelihood Ratio 0.0026
Table 9: Associations Between BMI, Hypertension Status, and Placental Malaria
Variable OR 95% CI SE P-value
BMI 0.0346 0.175 – 0.683 0.3469 0.002
Hypertension status 0.718 0.381 – 1.352 0.3228 0.305
Underweight by Hypertensive 0.045 0.003 – 0.788 1.4617 0.034
Normal BMI by No Hypertension 0.149 0.038 – 0.578 0.6914 0.006
Normal BMI by Hypertensive 0.571 0.101 – 3.226 0.8833 0.526
Overweight by No Hypertension 0.408 0.186 – 0.895 0.4012 0.025
Overweight by Hypertensive 0.375 0.134 – 1.046 0.5232 0.061
 

References

  1. Obiri D, Erskine IJ, Oduro D, Kusi KA, Amponsah J, Gyan BA, Adu-Bonsaffoh K, Ofori MF. Histopathological lesions and exposure to Plasmodium falciparum infections in the placenta increases the risk of preeclampsia among pregnant women. Sci Rep. 2020;10(1):8280. Available from: https://www.nature.com/articles/s41598-020-64736-4. doi:10.1038/s41598-020-64736-4.
  2. Ohiagu FO, Chikezie PC, Ahaneku CC, Chikezie CM, Law-Obi FC. Pathophysiology of severe malaria infection. Asian J Health Sci. 2021;7(2):22. Available from: http://ajhs.biomedpress.org/index.php/ajhs/article/view/492. doi:10.15419/ajhs.v7i2.492.
  3. Cutts JC, Agius PA, Zaw Lin, Powell R, Moore K, Draper B, Simpson JA, Fowkes FJ. Pregnancy-specific malarial immunity and risk of malaria in pregnancy and adverse birth outcomes: a systematic review. BMC Med. 2020;18(1):14. Available from: https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-019-1467-6. doi:10.1186/s12916-019-1467-6.
  4. Yadav V, Bairwa M, Dabar D, Goel AD, Palepu S, Joshi A. A systematic review and meta-analysis protocol on the association of malaria in pregnancy and adverse birth outcomes [preprint]. medRxiv. 2020 Jul 21 [cited 2025 Jul 23]. Available from: http://medrxiv.org/lookup/doi/10.1101/2020.07.19.20157081. doi:10.1101/2020.07.19.20157081.
  5. Oladipo HJ, Tajudeen YA, Oladunjoye IO, Yusuff SI, Yusuf RO, Oluwaseyi EM, AbdulBasit MO, Adebisi YA, El-Sherbini MS. Increasing challenges of malaria control in sub-Saharan Africa: priorities for public health research and policymakers. Ann Med Surg (Lond). 2022;81:104366. Available from: https://journals.lww.com/10.1016/j.amsu.2022.104366. doi:10.1016/j.amsu.2022.104366.
  6. Iwuchukwu I, Vincent C. Studies on prevalence of malaria and its adverse fetal outcomes in Federal Medical Centre (FMC), Owerri, Imo State, Nigeria. Arch Community Med Public Health. 2021;7:151-63. Available from: https://www.healthdisgroup.com/articles/ACMPH-7-256.php. doi:10.17352/2455-5479.000156.
  7. Mokuolu OA, Falade CO, Orogade AA, Okafor HU, Adedoyin OT, Oguonu TA, Dada-Adegbola HO, Oguntayo OA, Ernest SK, Hamer DH, et al. Malaria at parturition in Nigeria: current status and delivery outcome. Infect Dis Obstet Gynecol. 2009;2009:473971. Available from: http://www.hindawi.com/journals/idog/2009/473971/. doi:10.1155/2009/473971.
  8. Iyare F, Uneke C. Effect of placental malaria on placental and neonatal birthweight of primigravidae in Southeastern Nigeria. Niger J Exp Clin Biosci. 2018;6(2):59-65. Available from: http://www.njecbonline.org/text.asp?2018/6/2/59/252844. doi:10.4103/njecp.njecp_19_18.
  9. Ezebialu IU, Eke AC, Ezeagwuna DA, Nwachukwu CE, Ifediata F, Ezebialu CU. Prevalence, pattern, and determinants of placental malaria in a population of southeastern Nigerian parturients. Int J Infect Dis. 2012;16(12):e860-5. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1201971212012192. doi:10.1016/j.ijid.2012.07.014.
  10. Oranuka KR, Chama C, Adogu IO, Okafor CG, Eleje GU, Ugwu EO, Adeleke OP, Obakpororo PH, Nnabuchi KO, Yusuf A, et al. Placental malaria and its relationship with neonatal birth weight among primigravidae: an analytical cross-sectional study. Explor Res Hypothesis Med. 2024;9(3):181-91. Available from: https://www.xiahepublishing.com/2472-0712/ERHM-2023-00015. doi:10.14218/ERHM.2023.00015.
  11. Mukala J, Mogere D, Kirira P, Kanoi BN, Akisa V, Kobia F, Waweru H, Gitaka J. Predictors of birth weight in pregnant women with malaria: a prospective cohort facility-based study in Webuye-Kenya. BMC Pregnancy Childbirth. 2024;24(1):187. Available from: https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-024-06355-9. doi:10.1186/s12884-024-06355-9.
  12. Kitojo C, Chacky F, Kigadye ES, Mugasa JP, Lusasi A, Mohamed A, Walker P, Reaves EJ, Gutman JR, et al. Evaluation of a single screen and treat strategy to detect asymptomatic malaria among pregnant women from selected health facilities in Lindi region, Tanzania. Malar J. 2020;19(1):438. Available from: https://malariajournal.biomedcentral.com/articles/10.1186/s12936-020-03513-0. doi:10.1186/s12936-020-03513-0.
  13. Mangusho C, Mwebesa E, Izudi J, Aleni M, Dricile R, Ayiasi RM, Legason ID. High prevalence of malaria in pregnancy among women attending antenatal care at a large referral hospital in northwestern Uganda: a cross-sectional study. PLoS One. 2023;18(4):e0283755. Ali MM, editor. Available from: https://dx.plos.org/10.1371/journal.pone.0283755. doi:10.1371/journal.pone.0283755.
  14. Yaro JB, Ouedraogo A, Diarra A, Sombié S, Ouedraogo ZA, Nébié I, Drakeley C, Sirima SB, Tiono AB, Lindsay SW, et al. Risk factors for Plasmodium falciparum infection in pregnant women in Burkina Faso: a community-based cross-sectional survey. Malar J. 2021;20(1):362. Available from: https://malariajournal.biomedcentral.com/articles/10.1186/s12936-021-03896-8. doi:10.1186/s12936-021-03896-8.
  15. Degarege A, Fennie K, Degarege D, Chennupati S, Madhivanan P. Improving socioeconomic status may reduce the burden of malaria in sub Saharan Africa: a systematic review and meta-analysis. PLoS One. 2019;14(1):e0211205. Carvalho LH, editor. Available from: https://dx.plos.org/10.1371/journal.pone.0211205. doi:10.1371/journal.pone.0211205.
  16. Emmanuel BN, Chessed G, Erukainure FE, Ekeuhie JC, Philips V. Prevalence of malaria parasite and its effects on some hematological parameters amongst pregnant women in Yola, Nigeria. J Umm Al-Qura Univ Appl Sci. 2024;10(1):200-10. Available from: https://link.springer.com/10.1007/s43994-023-00092-z. doi:10.1007/s43994-023-00092-z.
  17. Callaway LK, O’Callaghan M, McIntyre HD. Obesity and the hypertensive disorders of pregnancy. Hypertens Pregnancy. 2009;28(4):473-93. Available from: http://www.tandfonline.com/doi/full/10.3109/10641950802629626. doi:10.3109/10641950802629626.
  18. Nakanishi K, Saijo Y, Yoshioka E, Sato Y, Kato Y, Nagaya K, Takahashi S, Ito Y, Kobayashi S, Miyashita C, et al. Association between maternal multimorbidity and preterm birth, low birth weight and small for gestational age: a prospective birth cohort study from the Japan Environment and Children’s Study. BMJ Open. 2023;13(3):e069281. Available from: https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2022-069281. doi:10.1136/bmjopen-2022-069281.
  19. Lwamulungi E, Qureshi Z, Obimbo M, Ogutu O, Cheserem E, Kosgei RJ, Walong E, Inyangala D, Nyakundi GG, Ndavi PM, et al. Placental characteristics and neonatal weights among women with malaria-preeclampsia comorbidity and healthy pregnancies. PLoS One. 2023;18(10):e0291172. Dey SK, editor. Available from: https://dx.plos.org/10.1371/journal.pone.0291172. doi:10.1371/journal.pone.0291172.
  20. García-Basteiro AL, Quintó L, Macete E, Bardají A, González R, Nhacolo A, Sigauque B, Sacoor C, Rupérez M, Sicuri E, et al. Infant mortality and morbidity associated with preterm and small-for-gestational-age births in Southern Mozambique: a retrospective cohort study. PLoS One. 2017;12(2):e0172533. Simeoni U, editor. Available from: https://dx.plos.org/10.1371/journal.pone.0172533. doi:10.1371/journal.pone.0172533.
  21. Khan WA, Galagan SR, Prue CS, Khyang J, Ahmed S, Ram M, Alam MS, Haq MZ, Akter J, Glass G, et al. Asymptomatic Plasmodium falciparum malaria in pregnant women in the Chittagong Hill Districts of Bangladesh. PLoS One. 2014;9(5):e98442. Snounou G, editor. Available from: https://dx.plos.org/10.1371/journal.pone.0098442. doi:10.1371/journal.pone.0098442.
  22. Falade CO, Yusuf BO, Fadero FF, Mokuolu OA, Hamer DH, Salako LA. Intermittent preventive treatment with sulphadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria. Malar J. 2007;6:88. Available from: https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-6-88. doi:10.1186/1475-2875-6-88.
  23. Solanke BL, Soladoye DA, Birsirka IA, Abdurraheem A, Salau OR. Utilization of insecticide-treated nets and associated factors among childbearing women in Northern Nigeria. Malar J. 2023;22(1):184. Available from: https://malariajournal.biomedcentral.com/articles/10.1186/s12936-023-04620-4. doi:10.1186/s12936-023-04620-4.
  24. Peters GO, Naidoo M. Factors influencing intermittent preventive treatment for malaria prevention among pregnant women accessing antenatal care in selected primary health care facilities of Bwari Area Council, Abuja Nigeria. PLoS One. 2022;17(12):e0277877. Augusto O, editor. Available from: https://dx.plos.org/10.1371/journal.pone.0277877. doi:10.1371/journal.pone.0277877.
  25. Nganga N, Dettinger J, Kinuthia J, Baeten J, John-Stewart G, Gómez L, Marwa M, Ochieng B, Pintye J, Mugwanya K, et al. Prevalence and correlates of pregnancy self-testing among pregnant women attending antenatal care in western Kenya. PLoS One. 2021;16(11):e0258578. Wilunda C, editor. Available from: https://dx.plos.org/10.1371/journal.pone.0258578. doi:10.1371/journal.pone.0258578.
  26. Fagbamigbe AF, Olaseinde O, Setlhare V. Sub-national analysis and determinants of numbers of antenatal care contacts in Nigeria: assessing the compliance with the WHO recommended standard guidelines. BMC Pregnancy Childbirth. 2021;21(1):402. Available from: https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-021-03837-y. doi:10.1186/s12884-021-03837-y.
  27. Mubyazi GM, Magnussen P, Byskov J, Bloch P. Feasibility and coverage of implementing intermittent preventive treatment of malaria in pregnant women contacting private or public clinics in Tanzania: experience-based viewpoints of health managers in Mkuranga and Mufindi districts. BMC Health Serv Res. 2013;13:372. Available from: https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-13-372. doi:10.1186/1472-6963-13-372.
  28. Elbashir HM, Salih MM, Elhassan EM, Mohmmed AA, Elbashir MI, Adam I. Polymerase chain reaction and histology in diagnosis of placental malaria in an area of unstable malaria transmission in Central Sudan. Diagn Pathol. 2011;6:128. Available from: https://diagnosticpathology.biomedcentral.com/articles/10.1186/1746-1596-6-128. doi:10.1186/1746-1596-6-128.
  29. Fried M, Muehlenbachs A, Duffy PE. Diagnosing malaria in pregnancy: an update. Expert Rev Anti Infect Ther. 2012;10(10):1177-87. Available from: http://www.tandfonline.com/doi/full/10.1586/eri.12.98. doi:10.1586/eri.12.98.
  30. Megnekou R, Djontu JC, Nana BC, Bigoga JD, Fotso M, Fogang B, Leke RF. Accuracy of One Step malaria rapid diagnostic test (RDT) in detecting Plasmodium falciparum placental malaria infection in women living in Yaoundé, Cameroon. Malar J. 2018;17(1):450. Available from: https://malariajournal.biomedcentral.com/articles/10.1186/s12936-018-2595-8. doi:10.1186/s12936-018-2595-8.
  31. Kashif AH, Adam GK, Mohmmed AA, Elzaki SE, AbdelHalim AM, Adam I. Reliability of rapid diagnostic test for diagnosing peripheral and placental malaria in an area of unstable malaria transmission in Eastern Sudan. Diagn Pathol. 2013;8:59. Available from: https://diagnosticpathology.biomedcentral.com/articles/10.1186/1746-1596-8-59. doi:10.1186/1746-1596-8-59.
  32. Kyabayinze DJ, Tibenderana JK, Nassali M, Tumwine LK, Riches C, Montague M, Counihan H, Hamade P, Van Geertruyden JP, Meek S. Placental Plasmodium falciparum malaria infection: operational accuracy of HRP2 rapid diagnostic tests in a malaria endemic setting. Malar J. 2011;10:306. Available from: https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-10-306. doi:10.1186/1475-2875-10-306.
  33. Natama HM, Traoré TE, Rouamba T, Somé MA, Zango SH, Rovira-Vallbona E, Sorgho H, Guetens P, Coulibaly-Traoré M, Valéa I, et al. Performance of PfHRP2-RDT for malaria diagnosis during the first year of life in a high malaria transmission area in Burkina Faso. J Parasit Dis. 2023;47(2):280-9. Available from: https://link.springer.com/10.1007/s12639-023-01566-x. doi:10.1007/s12639-023-01566-x.
  34. Umbers AJ, Unger HW, Rosanas-Urgell A, Wangnapi RA, Kattenberg JH, Jally S, Silim S, Lufele E, Karl S, Ome-Kaius M, et al. Accuracy of an HRP-2/panLDH rapid diagnostic test to detect peripheral and placental Plasmodium falciparum infection in Papua New Guinean women with anaemia or suspected malaria. Malar J. 2015;14:412. Available from: http://www.malariajournal.com/content/14/1/412. doi:10.1186/s12936-015-0927-5.
  35. Mekonen B, Dugassa S, Feleke SM, Dufera B, Gidisa B, Adamu A, Mandefro A, Tasew G, Golassa L. Widespread pfhrp2/3 deletions and HRP2-based false-negative results in southern Ethiopia. Malar J. 2024;23(1):108. Available from: https://malariajournal.biomedcentral.com/articles/10.1186/s12936-024-04904-3. doi:10.1186/s12936-024-04904-3.
  36. Da Silva C, Tembisse D, Cisteró P, Rovira-Vallbona E, Canana N, Da Costa P, Matambisso G, Aranda-Díaz A, Mbeve H, Ndimande N, et al. Molecular surveillance of Plasmodium falciparum histidine-rich protein 2/3 gene deletions in Mozambique, 2023. Malar J. 2024;23(1):402. Available from: https://malariajournal.biomedcentral.com/articles/10.1186/s12936-024-05230-4. doi:10.1186/s12936-024-05230-4.
  37. Unwin VT, Ahmed R, Noviyanti R, Puspitasari AM, Utami RA, Trianty L, Lukito T, Syafruddin D, Poespoprodjo JR, Santana-Morales MA, et al. Use of a highly-sensitive rapid diagnostic test to screen for malaria in pregnancy in Indonesia. Malar J. 2020;19(1):28. Available from: https://malariajournal.biomedcentral.com/articles/10.1186/s12936-020-3110-6. doi:10.1186/s12936-020-3110-6.
  38. Adebusuyi SA, Olorunfemi AB, Fagbemi KA, Nderu D, Amoo AO, Thomas BN, Velavan TP, Ojurongbe O. Performance of rapid diagnostic test, light microscopy, and polymerase chain reaction in pregnant women with asymptomatic malaria in Nigeria. IJID Reg. 2024;12:100416. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2772707624000870. doi:10.1016/j.ijregi.2024.100416.
  39. Nigeria National Bureau of Statistics. Demographic statistics bulletin December 2023. Abuja: Nigeria National Bureau of Statistics; 2023 Dec.
  40. Njoku EA, Tenenbaum DE. Quantitative assessment of the relationship between land use/land cover (LULC), topographic elevation and land surface temperature (LST) in Ilorin, Nigeria. Remote Sens Appl Soc Environ. 2022;27:100780. Available from: https://linkinghub.elsevier.com/retrieve/pii/S235293852200088X. doi:10.1016/j.rsase.2022.100780.
  41. Nigeria Meteorological Agency (NiMet). 2022 seasonal climate prediction. Abuja: Nigeria Meteorological Agency; 2022.
  42. Cochran WG. Sampling techniques. 3rd ed. New York (NY): John Wiley & Sons; 1977.
  43. Naing L, Winn T, Rusli BN. Practical issues in calculating the sample size for prevalence studies. Arch Orofac Sci. 2006;1:9-14. Available from: https://aos.usm.my/docs/Vol_1/09_14_ayub.pdf.
  44. Igbokwe U, Ibrahim R, Aina M, Umar M, Salihu M, Omoregie E, Sadiq FU, Obonyo B, Muhammad R, Saliu M, et al. Evaluating the implementation of the National Primary Health Care Development Agency (NPHCDA) gateway for the Basic Healthcare Provision Fund (BHCPF) across six northern states in Nigeria. BMC Health Serv Res. 2024;24(1):1404. Available from: https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-024-11867-3. doi:10.1186/s12913-024-11867-3.
  45. Egwuenu A, Ejikeme A, Tomczyk S, Von Laer A, Ayobami O, Odebajo O, Akhibi S, Agulanna C, Osagie O, Inweregbu US, et al. Baseline study for improving diagnostic stewardship at secondary health care facilities in Nigeria. Antimicrob Resist Infect Control. 2022;11(1):65. Available from: https://aricjournal.biomedcentral.com/articles/10.1186/s13756-022-01080-4. doi:10.1186/s13756-022-01080-4.
  46. Okonta KE, Okonta OC. Industrial crises in a tertiary health institution (THI) in Nigeria: the perspective of resident doctors. Int J Healthc Manag. 2018;11(4):269-75. Available from: https://www.tandfonline.com/doi/full/10.1080/20479700.2017.1397323. doi:10.1080/20479700.2017.1397323.
  47. Omer SA, Idress HE, Adam I, Abdelrahim M, Noureldein AN, Abdelrazig AM, Elhassan MO, Sulaiman SM. Placental malaria and its effect on pregnancy outcomes in Sudanese women from Blue Nile State. Malar J. 2017;16(1):374. Available from: http://malariajournal.biomedcentral.com/articles/10.1186/s12936-017-2028-0. doi:10.1186/s12936-017-2028-0.
  48. Anchang-Kimbi JK, Achidi EA, Nkegoum B, Sverremark-Ekström E, Troye-Blomberg M. Diagnostic comparison of malaria infection in peripheral blood, placental blood and placental biopsies in Cameroonian parturient women. Malar J. 2009;8:126. Available from: https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-8-126. doi:10.1186/1475-2875-8-126.
  49. Loscertales MP, Brabin BJ. ABO phenotypes and malaria related outcomes in mothers and babies in The Gambia: a role for histo-blood groups in placental malaria? Malar J. 2006;5:72. Available from: https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-5-72. doi:10.1186/1475-2875-5-72.
  50. Adesina AF, Peterside O, Anochie I, Akani NA. Weight status of adolescents in secondary schools in Port Harcourt using Body Mass Index (BMI). Ital J Pediatr. 2012;38:31. Available from: https://ijponline.biomedcentral.com/articles/10.1186/1824-7288-38-31. doi:10.1186/1824-7288-38-31.
  51. Joseph-Shehu EM, Ncama BP. Evaluation of health status and its predictor among university staff in Nigeria. BMC Cardiovasc Disord. 2018;18(1):183. Available from: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-018-0918-x. doi:10.1186/s12872-018-0918-x.
  52. Cardona-Arias JA, Carmona-Fonseca J. Frequency of placental malaria and its associated factors in northwestern Colombia, pooled analysis 2009–2020. PLoS One. 2022;17(5):e0268949. Adam I, editor. Available from: https://dx.plos.org/10.1371/journal.pone.0268949. doi:10.1371/journal.pone.0268949.
  53. Briggs AM, Shiffman J, Shawar YR, Åkesson K, Ali N, Woolf AD. Global health policy in the 21st century: challenges and opportunities to arrest the global disability burden from musculoskeletal health conditions. Best Pract Res Clin Rheumatol. 2020;34(5):101549. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1521694220300668. doi:10.1016/j.berh.2020.101549.
  54. Babamale AO, Abdulkareem AO, Yinka OJ, Folasade K, Olatundun BO, Ayodipo OF, Uddin MM, Ugbomoiko US. High parasitaemia correlates with malaria episodes and the socioeconomic impact of recurrent malaria infection in high-transmission zone of Nigeria. Bull Natl Res Cent. 2022;46(1):147. Available from: https://BNRC.springeropen.com/articles/10.1186/s42269-022-00846-5. doi:10.1186/s42269-022-00846-5.
  55. Abdulkarim IA, Yakudima II, Abdullahi JG, Adamu YM. Geographical analysis of malaria in Nigeria – spatiotemporal patterns of national and subnational incidence. In: Adewoyin Y, editor. Health and medical geography in Africa. Cham: Springer; 2023. p. 185-209. Available from: https://link.springer.com/10.1007/978-3-031-41268-4_9. doi:10.1007/978-3-031-41268-4_9.
  56. Obeagu EI, Obeagu GU. Emerging public health strategies in malaria control: innovations and implications. Ann Med Surg (Lond). 2024;86(11):6576-84. Available from: https://journals.lww.com/10.1097/MS9.0000000000002578. doi:10.1097/MS9.0000000000002578.
  57. Bardoe D, Bio RB, Yar DD, Hayford D. Assessing the prevalence, risk factors, and socio-demographic predictors of malaria among pregnant women in the Bono East Region of Ghana: a multicentre hospital-based mixed-method cross-sectional study. Malar J. 2024;23(1):302. Available from: https://malariajournal.biomedcentral.com/articles/10.1186/s12936-024-05120-9. doi:10.1186/s12936-024-05120-9.
  58. Awosolu OB, Yahaya ZS, Farah Haziqah MT, Simon-Oke IA, Fakunle C. A cross-sectional study of the prevalence, density, and risk factors associated with malaria transmission in urban communities of Ibadan, Southwestern Nigeria. Heliyon. 2021;7(1):e05975. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2405844021000803. doi:10.1016/j.heliyon.2021.e05975.
  59. Kalinjuma AV, Darling AM, Mugusi FM, Abioye AI, Okumu FO, Aboud S, Masanja H, Hamer DH, Hertzmark E, Fawzi WW. Factors associated with sub-microscopic placental malaria and its association with adverse pregnancy outcomes among HIV-negative women in Dar es Salaam, Tanzania: a cohort study. BMC Infect Dis. 2020;20(1):796. Available from: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-020-05521-6. doi:10.1186/s12879-020-05521-6.
  60. Aberese-Ako M, Magnussen P, Ampofo GD, Gyapong M, Ansah E, Tagbor H. An ethnographic study of how health system, socio-cultural and individual factors influence uptake of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a Ghanaian context. PLoS One. 2021;16(10):e0257666. Chico RM, editor. Available from: https://dx.plos.org/10.1371/journal.pone.0257666. doi:10.1371/journal.pone.0257666.
  61. Nyaaba GN, Olaleye AO, Obiyan MO, Walker O, Anumba DO. A socio-ecological approach to understanding the factors influencing the uptake of intermittent preventive treatment of malaria in pregnancy (IPTp) in South-Western Nigeria. PLoS One. 2021;16(3):e0248412. Thet Wai K, editor. Available from: https://dx.plos.org/10.1371/journal.pone.0248412. doi:10.1371/journal.pone.0248412.
  62. Mejia P, Treviño-Villarreal JH, De Niz M, Meibalan E, Longchamp A, Reynolds JS, Turnbull LB, Opoka RO, Roussilhon C, Spielmann T, et al. Adipose tissue parasite sequestration drives leptin production in mice and correlates with human cerebral malaria. Sci Adv. 2021;7(13):eabe2484. Available from: https://www.science.org/doi/10.1126/sciadv.abe2484. doi:10.1126/sciadv.abe2484.
  63. Caputa G, Matsushita M, Sanin DE, Kabat AM, Edwards-Hicks J, Grzes KM, Pohlmeyer R, Stanczak MA, Castoldi A, Cupovic J, et al. Intracellular infection and immune system cues rewire adipocytes to acquire immune function. Cell Metab. 2022;34(5):747-760.e6. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1550413122001358. doi:10.1016/j.cmet.2022.04.008.
  64. Cotter SC, Al Shareefi E. Nutritional ecology, infection and immune defence — exploring the mechanisms. Curr Opin Insect Sci. 2022;50:100862. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2214574521001310. doi:10.1016/j.cois.2021.12.002.
  65. Rattanapan Y, Duangchan T, Wangdi K, Mahittikorn A, Kotepui M. Association between rhesus blood groups and malaria infection: a systematic review and meta-analysis. Trop Med Infect Dis. 2023;8(4):190. Available from: https://www.mdpi.com/2414-6366/8/4/190. doi:10.3390/tropicalmed8040190.
  66. Oleinikov AV. Malaria parasite Plasmodium falciparum proteins on the surface of infected erythrocytes as targets for novel drug discovery. Biochemistry (Mosc). 2022;87(Suppl 1):S192-202. Available from: https://link.springer.com/10.1134/S0006297922140152. doi:10.1134/S0006297922140152.
  67. Rowe JA, Handel IG, Thera MA, Deans AM, Lyke KE, Koné A, Diallo DA, Raza A, Kai O, Marsh K, et al. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci U S A. 2007;104(44):17471-6. Available from: https://pnas.org/doi/full/10.1073/pnas.0705390104. doi:10.1073/pnas.0705390104.
  68. Ouma P, Van Eijk AM, Hamel MJ, Parise M, Ayisi JG, Otieno K, Kager PA, Slutsker L. Malaria and anaemia among pregnant women at first antenatal clinic visit in Kisumu, western Kenya. Trop Med Int Health. 2007;12(12):1515-23. Available from: https://onlinelibrary.wiley.com/doi/10.1111/j.1365-3156.2007.01960.x. doi:10.1111/j.1365-3156.2007.01960.x.
Views: 73

Login

Register

terms & conditions